FEB 08, 2017 12:00 PM PST

Availability and Management of Genetically Engineered Swine Models for Biomedical Research

Speaker

Abstract

DATE: February 8, 2017
TIME: 12:00pm PT, 3:00pm ET

Large animal models have recently become a staple in biomedical research.  The pig’s similarities to humans in terms of genetics, anatomy, and physiology have allowed the pig to gain momentum as a biomedical model.  On a nucleotide basis, the pig genome is 3 times closer to the human than rodents are to humans.  Although there are some anatomical differences between the human and pig, the pig is still becoming the model of choice for many human diseases.  In 2003, the National Institutes of Health developed the infrastructure for a central resource center for swine models for human health and diseases.  The National Swine Resource and Research Center (NSRRC) was developed to provide valuable swine models to investigators across the country.  Currently, the NSRRC has 60 models available to the scientific community with an additional 15 models in various stages of production and characterization.   Management of genetically modified swine models can range from standard housing to highly specialized housing which may be necessary for the disease model.   Maintenance or breeding of genetically modified swine models also ranges from strains being maintained in the heterozygous/monoallelic state while others can be maintained in the homozygous/biallelic state.  Although there may be specialized needs for some models, in general genetically modified swine models can be maintained as any other research pigs.  Biomedical research for human health and disease has begun to incorporate the swine model as the large animal of choice.  

Learning Objectives:

  • To determine the availability of swine models for investigators to request
  • To determine specific management skills for genetically modified swine models

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
FEB 08, 2017 12:00 PM PST

Availability and Management of Genetically Engineered Swine Models for Biomedical Research


Specialty

Molecular Biology

Animal Models

Animal Research

Biomarkers

Anesthetics

Protein

Immunology

Animal Sciences

Clinical Chemistry

Animal Welfare

Cancer Diagnostics

Biomedical Engineering

Antibodies

Cellular Mechanism

Anatomy

Geography

Europe50%

North America33%

Asia17%

Registration Source

Website Visitors100%

Job Title

Medical Laboratory Technician50%

Animal Care Lab Technician17%

Engineer17%

Scientist17%

Organization

Academic Institution33%

Hospital17%

Research Institute17%

Distribution/sales17%

Pharmaceutical Company17%


Show Resources
Loading Comments...
Show Resources